 of sustained beneﬁt to the patient (>50%
likelihood of clinical efﬁcacy for at least 2 years). For revascularization, anatomic patency
(freedom from hemodynamically signiﬁcant restenosis) is considered a prerequisite for sustained
efﬁcacy.

Grade

Level of
evidence

1

B

1

C

EVT, Endovascular therapy.
may be justiﬁed is to provide vascular access for another